Live
- NewsClick, others went to great lengths to paint CAA as discriminatory law targeting Muslims: Delhi Police charge sheet
- Illegal mining in Rajasthan: 4 FIRs lodged, 27 vehicles impounded
- Schools bomb threat: 125 calls received at police emergency number, says FIR
- In Gujarat, PM Modi's no-holds-barred attack on Cong, INDIA bloc over Pak's love for 'Shehzada' & 'vote jihad'
- BJP MP candidate Potuganti Bharat Prasad participated in the election campaign
- Over 97 per cent of Rs 2,000 banknotes returned: RBI
- India's coal output rises 7.4 per cent to 73.26 million tonnes in April
- Covaxin has excellent safety record, says Bharat Biotech
- Gold production from Indian mines surges by 86 pc in Feb, copper output up 29 pc
- AAP has formed a team to coordinate its election campaign with Congress
Alembic Pharma net up 37% to Rs 124 crores
Highlights
Alembic Pharmaceuticals on Monday posted a 36.75 per cent rise in its consolidated net profit to Rs 123.72 crore for the first quarter ended June 30, driven by robust sales in the US market.
New Delhi: Alembic Pharmaceuticals on Monday posted a 36.75 per cent rise in its consolidated net profit to Rs 123.72 crore for the first quarter ended June 30, driven by robust sales in the US market.
The drug firm had reported a net profit of Rs 90.47 crore in the corresponding period of 2018-19.
Revenue from operations rose to Rs 948.91 crore in the June quarter as compared with Rs 862.53 crore in the year-ago period, Alembic Pharmaceuticals said in a regulatory filing.
Next Story
ADVERTISEMENT
